Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI
Clinical trial NCT03153319 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03153319
- Sponsor
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-05
- Primary completion
- 2027-01-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.